SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Residual risk estimates of transfusion transmissible hepatitis B, hepatitis C and human immunodeficiency virus using nucleic acid testing yield/window period model in an Indian setting
12 references·2 citing·39 second hop
Residual risk estimates of transfusion transmissible hepatitis B, hepatitis C and human immunodeficiency virus using nucleic acid testing yield/window period model in an Indian setting (2022)Residual risk estimates of transfusion tr…HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12‐month deferral policy for men who have sex with men (2021)HIV, HCV, and HBV incidence a…A national level estimation of population need for blood in India (2021)A national level estimation o…Seroprevalence & changing trends of transfusion-transmitted infections amongst blood donors in a Regional Blood Transfusion Centre in north India (2017)Seroprevalence & changing tre…Residual risk of HIV, HCV and HBV in Canada (2017)Residual risk of HIV, HCV and…Nucleic acid amplification testing in Indian blood banks: A review with perspectives (2017)Nucleic acid amplification te…Comparison of Procleix Ultrio Elite and Procleix Ultrio NAT Assays for Screening of Transfusion Transmitted Infections among Blood Donors in India (2016)Comparison of Procleix Ultrio…Transfusion transmissible infections among blood donors from a sub-Himalayan rural tertiary care centre in Darjeeling, India (2015)Transfusion transmissible inf…Trends of transfusion transmissible diseases among blood donors at Uttarakhand, India (2014)Trends of transfusion transmi…Estimating window period blood donations for human immunodeficiency virus T ype 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern P akistan (2014)Estimating window period bloo…Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms (2010)Refinement of a viral transmi…Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors. (2008)Multicenter evaluation of ind…A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)A new strategy for estimating…A comparative analysis between NAT and chemiluminescence in detection of transfusion transmitted viruses in two main university blood transfusion centers (2025)A comparative analysis betwee…Effectiveness of Using Nucleic Acid Amplification Test to Screen Blood Donors for Hepatitis B, Hepatitis C, and HIV: A Tertiary Care Hospital Experience From Pakistan (2023)Effectiveness of Using Nuclei…Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary blood donors in western India. (2001)Seroprevalence of HIV, HBV, HCV and syphilis in voluntary blood donors. (2004)Prevalence and Trends of Markers of Hepatitis C Virus, Hepatitis B Virus and Human Immunodeficiency Virus in Delhi Blood Donors: A Hospital Based Study (2007)Seroprevalence and diagnosis of HIV, HBV, HCV and syphilis infections among blood donors (2016)Seroprevalence and Trends of Transfusion Transmissible Infections in Blood Donors in Andaman and Nicobar Islands- An Institutional Retrospective Study (2017)Blood Transfusion-Associated Infections in the Twenty-First Century: New Challenges (2020)The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations (2003)Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus (2008)Seroprevalence of transfusion-transmissible infectious agents among volunteer blood donors between 2006 and 2012 in Zhejiang, China. (2015)The Risk of Transfusion-Transmitted Viral Infections (1996)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Prevention of transfusion-transmitted infections (2019)Impact of individual‐donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa (2009)Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion (2009)Assessment of HIV transfusion transmission risk in South Africa: a 10‐year analysis following implementation of individual donation nucleic acid amplification technology testing and donor demographics eligibility changes (2018)Screening Blood Donors for HIV, HCV, and HBV at the American Red Cross: 10-Year Trends in Prevalence, Incidence, and Residual Risk, 2007 to 2016 (2020)Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing (2010)Compliance with time‐based deferrals for men who have sex with men (2019)Risks and challenges of HIV infection transmitted via blood transfusion (2019)HIV incidence and compliance with deferral criteria over three progressively shorter time deferrals for men who have sex with men in Canada (2021)Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing (2005)Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT) (2005)Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6‐year survey (2008)Initial trends of individual donation nucleic acid testing in voluntary & replacement donors from a tertiary care centre in north India (2019)Seven Years Experience in NAT Testing of Blood Donors in a Tertiary Care Centre (2019)Transfusion-transmitted infections (2007)Seroprevalence of HIV, HBV, HCV and syphilis in blood donors in Southern Haryana (2010)Transfusion Transmissible Infections Among Voluntary Blood Donors at Dessie Blood Bank, Northeast Ethiopia: Cross-Sectional Study (2020)Degree of blood safety of voluntary non‐remunerated versus replacement blood donations: A multi‐centre study of the large cohort of blood donors from two provinces of Pakistan (2023)Prevalence and Risk Factors of Transfusion‐Transmissible Infections Among Voluntary Blood Donors in North Shoa, Amhara Region, Ethiopia: A Cross‐Sectional Study (2025)Sero-prevalence and Changing Trends of Transfusion Transmitted Infections among Blood Donors in a Tertiary Care Hospital (2015)Seroprevalence of Transfusion Transmitted Infections among blood donors in a Tertiary care Hospital in Andhra Pradesh (2018)Trends of Infectious Disease Markers Among Healthy Blood Donors In Northern India: A Ten Year Study (2022)Leveraging Donor Populations to Study the Epidemiology and Pathogenesis of Transfusion-Transmitted and Emerging Infectious Diseases (2023)International review of blood donation nucleic acid amplification testing (2024)Need for Nucleic Acid Testing in Countries with High Prevalence of Transfusion-Transmitted Infections (2012)Nucleic acid testing for blood banks: An experience from a tertiary care centre in New Delhi, India (2013)Assessing the global burden of hemorrhage: The global blood supply, deficits, and potential solutions (2021)
this work references cited by second hop

References

  • 2005A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors426 cited
  • 2010Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms131 cited
  • 2008Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors.73 cited
  • 2021HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12‐month deferral policy for men who have sex with men52 cited
  • 2015Transfusion transmissible infections among blood donors from a sub-Himalayan rural tertiary care centre in Darjeeling, India45 cited
  • 2017Residual risk of HIV, HCV and HBV in Canada45 cited
  • 2017Nucleic acid amplification testing in Indian blood banks: A review with perspectives39 cited
  • 2017Seroprevalence & changing trends of transfusion-transmitted infections amongst blood donors in a Regional Blood Transfusion Centre in north India28 cited
  • 2014Trends of transfusion transmissible diseases among blood donors at Uttarakhand, India24 cited
  • 2014Estimating window period blood donations for human immunodeficiency virus T ype 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern P akistan19 cited
  • 2021A national level estimation of population need for blood in India18 cited
  • 2016Comparison of Procleix Ultrio Elite and Procleix Ultrio NAT Assays for Screening of Transfusion Transmitted Infections among Blood Donors in India

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

15 cited

Cited by

  • 2025A comparative analysis between NAT and chemiluminescence in detection of transfusion transmitted viruses in two main university blood transfusion centers8 cited
  • 2023Effectiveness of Using Nucleic Acid Amplification Test to Screen Blood Donors for Hepatitis B, Hepatitis C, and HIV: A Tertiary Care Hospital Experience From Pakistan6 cited